Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.89 |
| ▸ | CA4 | P22748 | 3/20 | 0.73 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LDHA | P00338 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL9116209 | 1.00 | CA1 (0.89) | CA1CA4FAHD1LMNATSHR | |
| Acetic Acid SCHEMBL9118173 | 1.00 | CA1 (0.89) | CA1CA4FAHD1LMNATSHR | |
| Acetic Acid SCHEMBL9117468 | 1.00 | CA1 (0.89) | CA1CA4FAHD1LMNATSHR | |
| Acetic Acid SCHEMBL4655822 | 1.00 | CA1 (0.89) | CA1CA4FAHD1LMNATSHR | |
| Acetic Acid SCHEMBL9117998 | 1.00 | CA1 (0.89) | CA1CA4FAHD1LMNATSHR | |
| Acetic Acid SCHEMBL1254 | 1.00 | — | — | |
| Acetic Acid SCHEMBL3447879 | 1.00 | CA1 (0.89) | CA1CA4FAHD1LMNATSHR | |
| Acetic Acid SCHEMBL9120233 | 1.00 | CA1 (0.89) | CA1CA4FAHD1LMNATSHR | |
| Acetic Acid SCHEMBL2598301 | 0.95 | CA1 (0.90) | CA1CA4FAHD1LMNATSHR | |
| Acetic Acid SCHEMBL6278277 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709194-A2 | APPLE CIDER VINEGAR FORMULATION | Bragg Live Food Products, LLC (US) | 2026-03-18 | — | — | EP | claimed |
| US-20260071157-A1 | APPLE CIDER VINEGAR FORMULATION | BRAGG LIVE FOOD PRODUCTS LLC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4629828-A1 | PARTICULATE COMPOSITION COMPRISING DIACETATE COMPONENT, DISODIUM DIPHOSPHATE AND ANOTHER ORGANIC ACID SALT | Purac Biochem B.V. (NL) | 2025-10-15 | — | — | EP | claimed |
| US-20250295129-A1 | PARTICULATE COMPOSITION COMPRISING DIACETATE COMPONENT, DISODIUM DIPHOSPHATE AND ANOTHER ORGANIC ACID SALT | PURAC BIOCHEM B.V. (NL) | 2025-09-25 | — | — | US | claimed |
| US-20250064743-A1 | TREPROSTINIL DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | UNITED THERAPEUTICS CORPORATION (US) | 2025-02-27 | — | — | US | claimed |
| WO-2024233697-A2 | APPLE CIDER VINEGAR FORMULATION | Bragg Live Food Products, LLC (US) | 2024-11-14 | — | — | WO | claimed |
| WO-2024121025-A1 | PARTICULATE COMPOSITION COMPRISING DIACETATE COMPONENT, DISODIUM DIPHOSPHATE AND ANOTHER ORGANIC ACID SALT | PURAC BIOCHEM B.V. (NL) | 2024-06-13 | — | — | WO | claimed |
| CN-117479946-A | Dry powder compositions containing treprostinil and its prodrug and further comprising (E) -3,6-bis [4- (N-carbonyl-2-propenyl) amide butyl ] -2,5-diketopiperazine (FDKP) | 联合治疗公司 | 2024-01-30 | — | — | CN | claimed |
| US-20230380428-A1 | BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS | SUSTAINABLE COMMUNITY DEV LLC (US) | 2023-11-30 | — | — | US | claimed |
| CN-116178825-A | Preparation method of antibacterial plastic food packaging box | 江苏纯一新材料有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-112898456-B | Efficient mud-inhibiting type polycarboxylate superplasticizer and preparation method thereof | 山东交通学院 | 2022-06-21 | — | — | CN | claimed |
| CN-114561258-A | Ethylene unit alkaline washing tower detergent | 浙江杭化科技股份有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-112176126-B | Leather deliming agent free of nitrogen and boron elements and preparation method thereof | 四川亭江新材料股份有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-114437682-A | Fractured carbonate reservoir protection drilling fluid and preparation method thereof | 中国石油化工股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| WO-2022081174-A1 | BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS | SUSTAINABLE COMMUNITY DEVELOPMENT, LLC (US) | 2022-04-21 | — | — | WO | claimed |
| CN-113015718-A | Amorphous form of chelating agent and process for its preparation | 好利安科技有限公司 | 2021-06-22 | — | — | CN | claimed |
| CN-112516133-A | Application of salvianolate for injection in preparing antiviral drug | 南方医科大学 | 2021-03-19 | — | — | CN | claimed |
| CN-105902530-B | A kind of polydanshinolate lipid nano particle and preparation method | 浙江大学 | 2019-04-30 | — | — | CN | claimed |
| CN-105902530-A | Salvianolate lipid nanoparticle and preparation method thereof | 浙江大学 | 2016-08-31 | — | — | CN | claimed |
| CN-103417526-A | Application of salvianolate in preparation of kidney protective agent drugs | SHANGHAI GREENVALLEY PHARMACEUTICAL CO LTD | 2013-12-04 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250064743-A1 | TREPROSTINIL DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | TREH, THPO, TPP2 | CA1 4188/4885CA4 3934/4885FAHD1 789/4885 |
| US-20260071157-A1 | APPLE CIDER VINEGAR FORMULATION | FABP4, FFAR3, FFAR4 | CA1 897/4885CA4 446/4885FAHD1 1799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.